On November 17, 2022, Dr. Andrew Lo, a Class II director of Roivant Sciences Ltd. (the “Company”), informed the Company of his decision to resign from his role on the Company’s board of directors (the “Board”) effective immediately, to focus on other ventures.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Andrew Lo resigned as Class II director at Roivant Sciences Ltd..
Action
resigned
Role
Class II director
Exact text from the filing
On November 17, 2022, Dr. Andrew Lo, a Class II director of Roivant Sciences Ltd. (the “Company”), informed the Company of his decision to resign from his role on the Company’s board of directors (the “Board”) effective immediately, to focus on other ventures.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.